0
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2011;306(23):2537. doi:10.1001/jama.2011.1855.
Text Size: A A A
Published online

SLEEP DISORDERS IN POLICE OFFICERS

Police officers—who often work extended shifts—may experience chronic sleep deficiency or have untreated sleep disorders, which may adversely affect their health and safety. In a cross-sectional survey of 4957 North American police officers and prospective follow-up surveys completed by 3545 officers, Rajaratnam and colleagues found that 40% of the respondents screened positive for a sleep disorder, which was associated with increased risk of self-reported adverse health and job-related administrative errors and safety violations. In an editorial, Grandner and Pack discuss health and safety implications of sleep deprivation and untreated sleep disorders for individuals and society.

HEART RATE, ISCHEMIC HEART DISEASE, AND MORTALITY

High resting heart rate is a recognized predictor of cardiovascular morbidity and mortality, but whether temporal changes in resting heart rate influence the risk of death from ischemic heart disease is not known. Nauman and colleagues analyzed data from a prospective cohort study of 29 325 apparently healthy individuals who had resting heart rate measured on 2 occasions approximately 10 years apart. The authors report that an increase in resting heart rate over the 10-year period was associated with an increased risk of ischemic heart disease–related death.

CHLORTHALIDONE TREATMENT AND LONG-TERM SURVIVAL

In the Systolic Hypertension in the Elderly Program trial, in which 4736 older patients with isolated systolic hypertension were randomly assigned to chlorthalidone-based stepped-care therapy or placebo for 4.5 years, antihypertensive therapy resulted in a lower rate of cardiovascular events but effects on mortality were not significant. At a 22-year follow-up of the study participants, Kostis and colleagues found that 4.5 years' treatment with chlorthalidone-based therapy was associated with a gain in life expectancy free from cardiovascular death—corresponding to approximately 1 day gained for each month of treatment received.

IMMUNOSUPPRESSION IN SEPSIS

Some evidence suggests that in severe sepsis, an early hyperinflammatory response is followed by immunosuppression. In a study that involved postmortem spleen and lung tissue harvested from 40 patients who died with sepsis, 29 control spleens from critically ill patients without sepsis, and 20 control lungs from transplant donors or lung cancer resections, Boomer and colleagues assessed the association of sepsis with changes in host immunity. The authors report biochemical, flow cytometric, and immunohistochemical findings consistent with immunosuppression in tissue obtained from the patients who died with sepsis that were not observed in the control tissues. In an editorial, Ward discusses evidence for the development of immunosuppression in patients with sepsis. In a commentary Angus calls for a reevaluation of current modes of treating sepsis.

CLINICIAN'S CORNER
JAMA CLINICAL CHALLENGE

A patient who experienced the sensation of an object striking his right eye, without acute pain or change in vision, presented to the emergency department 9 days later for evaluation of increasingly blurred vision. What would you do next?

A PIECE OF MY MIND

“The central determinants of health care costs are physician habits, attitudes, and behaviors. In every clinical encounter, multiple decisions are made with significant financial consequences.” From “Fix It!”

MEDICAL NEWS & PERSPECTIVES

The recent recommendation by the US Preventive Services Task Force advising against prostate-specific antigen–based screening for prostate cancer has provoked considerable debate in the medical community.

COMMENTARIES

Accelerating identification and approval of cancer drugs

Homocysteine lowering: the role of subgroup analyses

Placebo effect in clinical practice

AUTHOR IN THE ROOM TELECONFERENCE

Join Harold C. Sox, MD, on Wednesday, January 18, at 2 PM eastern time to discuss the new American Cancer Society process for creating trust-worthy cancer screening guidelines. To register, go to http://www.ihi.org/AuthorintheRoom.

EDITOR'S AUDIO COMMENTARY

Dr Bauchner summarizes and comments on this week's issue. Go to http://jama.ama-assn.org/misc/audiocommentary.dtl.

READERS RESPOND

How would you manage care for a house officer with a needlestick injury? Go to www.jama.com to read the case. Submit your response by January 1.

JAMA PATIENT PAGE

For your patients: Information about frostbite.

First Page Preview

View Large
First page PDF preview

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.